Header Logo

Connection

DAVID QUACH to Immunotherapy, Adoptive

Back to Details
This is a "connection" page, showing publications DAVID QUACH has written about Immunotherapy, Adoptive.
DAVID QUACH
Connection Strength
0.152
Immunotherapy, Adoptive
  1. Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy. Cancer Immunol Res. 2024 Aug 01; 12(8):1108-1122.
    View in: PubMed
    Score: 0.152
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.